Literature DB >> 31725826

Status Change to Open Access After Publication.

.   

Abstract

Year:  2019        PMID： 31725826      PMCID： PMC8177348          DOI： 10.1001/jamaoncol.2019.5334

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  1 in total

1.  Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical Trial.

Authors:  Takayuki Yoshino; Takeharu Yamanaka; Eiji Oki; Masahito Kotaka; Dai Manaka; Tetsuya Eto; Junichi Hasegawa; Akinori Takagane; Masato Nakamura; Takeshi Kato; Yoshinori Munemoto; Shintaro Takeuchi; Hiroyuki Bando; Hiroki Taniguchi; Makio Gamoh; Manabu Shiozawa; Tsunekazu Mizushima; Shigetoyo Saji; Yoshihiko Maehara; Atsushi Ohtsu; Masaki Mori
Journal:  JAMA Oncol       Date:  2019-11-01       Impact factor: 31.777
  1 in total
  1 in total

1.  Errors in Table.

Authors: 
Journal:  JAMA Oncol       Date:  2020-02-01       Impact factor: 31.777
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.